Managers / Q2 2019 · view latest →
WASHINGTON TRUST BANK
CIK 0000861787 · POST OFFICE BOX 2127, PRIVATE BANKING, SPOKANE, WA, 99210-2127 · 5093534150
Summary
Washington Trust Bank reported $615M in U.S.-listed holdings across 328 positions for Q2 2019.
The portfolio is heavily concentrated: PCAR alone accounts for 21.0% of reported value.
Compared with Q1 2019, the fund opened 2 new positions and exited 411.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 84.2% · $518M
- ETP · 8.9% · $55M
- Other · 3.4% · $21M
- REIT · 3.4% · $21M
- ADR · 0.0% · $281,000
Quarter-over-Quarter Changes full breakdown →
vs Q1 2019 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| iShares ETFs/USA | NEW | +27.5K | 27.5K | +$3M | $3M |
| BlackRock Fund Advisors | NEW | +26.7K | 26.7K | +$1M | $1M |
| DowDuPont Inc | SOLD OUT | −5.8K | 0 | −$308,000 | $0 |
| Vanguard ETF/USA | SOLD OUT | −1.6K | 0 | −$273,000 | $0 |
| WISDOMTREE ASSET MANAGEMENT INC | SOLD OUT | −6.5K | 0 | −$257,000 | $0 |
| BPBP PLC | SOLD OUT | −5.3K | 0 | −$233,000 | $0 |
| ISHARES | SOLD OUT | −2.4K | 0 | −$232,000 | $0 |
| TSLATesla Inc | SOLD OUT | −806 | 0 | −$226,000 | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2019
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $1.4B | 348 | May 7, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $1.4B | 339 | Feb 4, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $1.4B | 342 | Oct 24, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $1.2B | 343 | Aug 6, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $998M | 345 | Apr 30, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $1.0B | 348 | Feb 11, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $1.0B | 359 | Oct 31, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $1.0B | 340 | Jul 29, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $1.0B | 381 | May 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $1.1B | 375 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $957M | 360 | Nov 6, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $980M | 368 | Aug 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | Under review | 368 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 381 | Feb 6, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $787M | 371 | Nov 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $779M | 363 | Aug 4, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $864M | 398 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $1.0B | 413 | Feb 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $856M | 364 | Oct 27, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $844M | 327 | Jul 28, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $812M | 333 | Apr 22, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $767M | 331 | Feb 8, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $676M | 304 | Nov 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $629M | 326 | Jul 29, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $521M | 313 | May 1, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $703M | 360 | Jan 29, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $611M | 323 | Oct 29, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $615M | 328 | Jul 26, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $627M | 822 | Apr 9, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $762M | 875 | Feb 13, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.